Fennec Pharmaceuticals Inc
Fennec Pharmaceuticals Inc (FENC) Covered Calls
Fennec Pharmaceuticals Inc trades in the Biotechnology industry with an IV Rank of 12.30%, low versus the past year. FENC's highest covered call setup is the $12.50 strike expiring May 21, 2027, sorted by theoretical annualized return. It's 7.57% out of the money with 189 days to expiration, a 8.43% return until expiration, and a 16.29% theoretical annualized return. Across the setups shown, annualized returns run from 16.29% to 16.29% at strikes between $12.50 and $12.50, with 189 to 189 days to expiration, as of Nov 13, 2026.
Read more
Running FENC covered calls helps you generate income from Fennec Pharmaceuticals Inc shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best FENC covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call pairs limited risk with a clear income profile. If FENC stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling FENC covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given FENC covered call is worth writing.
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.
| 2027-05-21 | 189 | 12.50 | 7.57 | 0.10 | 5.00 | 98.00 | 8.43 | 16.29 | -0.86 | +0.59 | 1 | 4.90 |
As of Nov 13, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV Rank12.30% Low
- Market cap (M$)451
- 52 weeks high-3.70%
- 52 weeks low125.84%
- Analyst recommendationStrong Buy
1.00 - Target price$17.40
26.66% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-12
- P/E764.07
- Future P/E13.07
- EPS (ttm)0.02
- EPS growth next 5 years—
As of Nov 16, 2026